Q32 Bio News and Activities

Q32 Bio is a company listed under the stock ticker QTTB (US).

View the org chart displaying its 25 main executives

Most searched biographies at Q32 Bio

• Jodie Morrison, Chief Executive Officer
• Diyong Xu, Director
• Davidi Grayzel, Director

Create your alert
to follow the executive moves at Q32 Bio.

Q32 Bio has 2,426 competitors including Lonza (Switzerland), Vertex Pharmaceuticals (United States (USA)) and Eurofins (Luxembourg).

Popular M&A news in Biotechnology

• The new name of ChemoTech is Neem’s Hill. (posted on July 15 2026).
• Archimed Group has acquired Esperion Therapeutics (posted on July 14 2026).
• MindRank has just announced a $52 Million fundraising (posted on July 14 2026).

Popular contacts in Biotechnology

• Jakob Uszkoreit - Co-Founder and Chief Executive Officer at Inceptive
• Jan Van de Winkel - President and Chief Executive Officer at Genmab
• Robert Gould - Board Member at Fulcrum Therapeutics

Learn more about the Biotechnology industry

Press releases by Q32 Bio

• Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program - Q32 Bio Inc.
• News Releases - Q32 Bio Inc.
• Q32 Bio Reports Third Quarter 2024 Financial Results and Provides Corporate Update - Q32 Bio Inc.
• News Releases - Q32 Bio Inc.
• News Releases - Q32 Bio Inc.
• News Releases - Q32 Bio Inc.
• News Releases - Q32 Bio Inc.
• Q32 Bio to Participate in Guggenheim's Inaugural Healthcare Innovation Conference - Q32 Bio Inc.
• Q32 Bio to Present Tissue-Targeted Complement Inhibitor ADX-097 Positive Phase 1 Clinical Trial Results at the American Society of Nephrology Kidney Week 2024 - Q32 Bio Inc.
• Q32 Bio to Participate in Upcoming September Investor Conferences - Q32 Bio Inc.
• View more press releases Close

Social media about Q32 Bio

• Q32 Bio on Wikipedia, Google News & Yahoo Finance
• Q32 Bio on LinkedIn, X (Twitter) & YouTube